Jennifer L. Taubert - 17 Aug 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Reporting relationship: EVP, WWC. Innovative Medicine
Issuer ticker: JNJ
Reported as of: 17 Aug 2026
Net transaction value: -$3,950,400
SEC form: 4
Accepted by SEC: 18 Aug 2026, 18:31:06 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Joleen Morgan, as attorney-in-fact for Jennifer Taubert

Key filing fact

Jennifer L. Taubert filed Form 4 for JOHNSON & JOHNSON (JNJ) on 18 Aug 2026.

Key facts

This page summarizes Jennifer L. Taubert's Form 4 filing for JOHNSON & JOHNSON (JNJ).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Aug 2026, 18:31.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: -$3,950,400.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001745938 Primary reporting owner

Taubert Jennifer L

Relationship: EVP, WWC. Innovative Medicine
Address: ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK
Signature: /s/ Joleen Morgan, as attorney-in-fact for Jennifer Taubert
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JNJ transaction

Common Stock

Options Exercise

Transaction value
Shares: +15,000
Change %: +7.7%
Price: $115.67^*
Shares after: 209,451
Date: 17 Aug 2026
Ownership: Direct

JNJ transaction

Common Stock

Sale

Transaction value: $3,950,400
Shares: -15,000
Change %: -7.2%
Price: $263.36
Shares after: 194,451
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JNJ transaction Derivative

Employee Stock Options (Right to Buy)

Options Exercise

Transaction value
Shares: -15,000
Change %: -34%
Price: $0.000000^*
Shares after: 28,712
Date: 17 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $115.67
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F2

Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.